Speaker: Hugo A. Katus, MD, Professor of Medicine, Universitaets-Klinkenshubeck, Luebeck, Germany.
Meeting Highlights: American College of Cardiology
A subgroup analysis of data from the COPERNICUS (Carvedilol Prospective Randomized Cumulative Survival) trial demonstrated that treatment with the beta blocker carvedilol (Coreg medication, Glaxo SmithKline) is effective and well-tolerated in patients with severe heart failure (HF) symptoms and an [...]

Speaker: Ron Waksman, MD, Clinical Professor of Medicine (Cardiology), Georgetown University School of Medicine, and Associate Director of the Division of Cardiology, Washington Hospital Center, Washington, DC.
Data from a comparison of patient registries of two studies to assess the value of 12 months of therapy with clopidogrel (Plavix generic, Sanofi Synthelabo/Bristol Myers Squibb) in patients [...]

Aldosterone Blocker in Diabetic Hypertensive Proteinuria
Speaker: Murray Epstein, MD, Professor of Medicine, Nephrology and Hypertension, University of Miami School of Medicine, Miami, Florida.
Eplerenone (Pharmacia), the first selective aldosterone blocker, provided substantial reduction in proteinuria in hypertensive patients with diabetes, compared to the ACE-inhibitor enalapril (Vasotec drug, Merck), with the two together being even more effective [...]